EGLUCENT MIX 50 PENFILL 3 ML

How EGLUCENT MIX 50 PENFILL 3 ML Works

• EGLUCENT MIX 50 PENFILL 3 ML is a premixed insulin formulation containing both rapid-acting and intermediate-acting insulin analogs. This combination helps to control blood sugar levels throughout the day by addressing both mealtime and basal insulin needs. The rapid-acting component, typically Insulin Lispro or Aspart, works quickly to cover the rise in blood glucose that occurs after eating. It starts to work within 10-20 minutes, peaks in about 1-2 hours, and lasts for approximately 3-5 hours. This rapid action helps to minimize post-meal blood sugar spikes, preventing hyperglycemia.
• The intermediate-acting component, usually Neutral Protamine Lispro (NPL) or Neutral Protamine Aspart (NPA), provides a longer-lasting background insulin coverage. It starts to work within 1-2 hours, peaks in 4-12 hours, and lasts for up to 24 hours. This helps to maintain stable blood sugar levels between meals and during the night, preventing hypoglycemia and hyperglycemia. By combining these two types of insulin, EGLUCENT MIX 50 PENFILL 3 ML offers a convenient way to manage blood sugar levels with fewer injections compared to using separate rapid-acting and intermediate-acting insulins.
• Specifically, the '50' in EGLUCENT MIX 50 indicates that the formulation contains 50% rapid-acting insulin and 50% intermediate-acting insulin. The rapid-acting insulin helps to quickly lower blood sugar levels after meals, while the intermediate-acting insulin provides a sustained release of insulin to help keep blood sugar levels stable throughout the day and night. This balanced combination ensures that both post-meal glucose excursions and basal insulin requirements are adequately addressed, leading to better overall glycemic control.
• The penfill device allows for accurate and convenient dosing. It's designed for subcutaneous injection, typically in the abdomen, thigh, or upper arm. The injection sites should be rotated to prevent lipohypertrophy (thickening of the skin) or lipoatrophy (loss of fat tissue). Proper injection technique is crucial for optimal absorption and effectiveness of the insulin. Always follow your healthcare provider's instructions regarding dosage, timing, and injection technique. Regular monitoring of blood glucose levels is essential to adjust the insulin dose as needed and to ensure that the blood sugar levels remain within the target range.
• In summary, EGLUCENT MIX 50 PENFILL 3 ML works by delivering a combination of rapid-acting and intermediate-acting insulin to manage blood sugar levels effectively. The rapid-acting component controls post-meal glucose spikes, while the intermediate-acting component provides sustained basal insulin coverage. This dual-action approach helps to achieve better glycemic control with fewer injections, improving overall diabetes management. Remember to always consult with your doctor or healthcare provider for personalized advice on using this medication.

Like all medicines, EGLUCENT MIX 50 PENFILL 3 ML can cause side effects, although not everybody gets them. **Common Side Effects (may affect up to 1 in 10 people):** * Hypoglycemia (low blood sugar): This is the most common side effect. Symptoms can include sweating, shakiness, anxiety, rapid heartbeat, dizziness, hunger, blurred vision, headache, and confusion. Severe hypoglycemia can lead to unconsciousness and, in very rare cases, may be fatal. * Injection site reactions: Redness, swelling, itching, or pain at the injection site. **Uncommon Side Effects (may affect up to 1 in 100 people):** * Lipodystrophy: Changes in fat tissue at the injection site (either thickening or pitting of the skin). * Allergic reactions: Skin rash, itching, hives. **Rare Side Effects (may affect up to 1 in 1,000 people):** * Severe allergic reaction (anaphylaxis): Symptoms can include difficulty breathing, wheezing, swelling of the face, tongue, or throat, and rapid heartbeat. This is a medical emergency. * Peripheral neuropathy (nerve damage): Can cause pain, numbness, or tingling in the hands or feet. **Very Rare Side Effects (may affect up to 1 in 10,000 people):** * Visual disturbances: Changes in vision may occur at the beginning of insulin treatment, but these are usually temporary. * Edema: Swelling of the ankles and feet due to fluid retention. **Other Possible Side Effects:** * Weight gain * Sodium retention **Important Information:** * If you experience any signs of a serious allergic reaction, seek immediate medical attention. * If you experience any other side effects, talk to your doctor or pharmacist.

• If you miss a dose of Eglucent Mix 50, take it as soon as you remember, unless it is almost time for your next dose. In that case, skip the missed dose and continue with your regular dosing schedule. Do not take a double dose to make up for the missed one, as this may increase the risk of hypoglycemia (low blood sugar).

• Keep EGLUCENT MIX 50 PENFILL 3ML away from the reach of children and pets.
• Store EGLUCENT MIX 50 PENFILL 3ML in a refrigerator (2 - 8°C). Do not freeze.

• Always store your EGLUCENT MIX 50 PENFILL 3 ML in the refrigerator between 2°C to 8°C (36°F to 46°F) before first use. Once in use, it can be stored at room temperature (below 25°C or 77°F) for up to 28 days, away from direct heat and light. Discard after 28 days, even if some insulin remains.
• Before each injection, gently roll the pen 10 times and then invert it 10 times to ensure the insulin is uniformly mixed. Do not shake vigorously, as this can create bubbles and affect the accuracy of the dose. Properly mixed insulin should appear uniformly cloudy.
• Inject EGLUCENT MIX 50 subcutaneously, meaning under the skin, into areas recommended by your doctor, such as the abdomen, thigh, or upper arm. Rotate injection sites to prevent lipohypertrophy (thickening of the skin) or lipoatrophy (thinning of the skin). Each injection should be at least 1 cm away from the previous one.
• Never share your EGLUCENT MIX 50 pen with anyone else, even if the needle is changed. Sharing insulin pens can transmit infectious diseases, such as hepatitis or HIV. Each pen is intended for single-patient use only.
• If you experience symptoms of hypoglycemia (low blood sugar), such as sweating, shaking, dizziness, or confusion, consume a fast-acting source of glucose, like juice, honey, or glucose tablets, and then check your blood sugar. If your blood sugar is still low after 15 minutes, repeat the process. Always carry a source of fast-acting glucose with you.
• Monitor your blood glucose levels regularly as directed by your healthcare provider. This will help you understand how EGLUCENT MIX 50 is affecting your blood sugar and allow you to adjust your dosage as needed. Keep a record of your blood glucose readings to share with your doctor during appointments.
• Prime the pen before each injection. This involves dialing up 2 units and injecting into the air. If no insulin comes out of the needle, repeat the process until you see a steady stream. This ensures that the pen is working correctly and that you receive the correct dose.
• Be aware of factors that can affect your blood sugar levels, such as diet, exercise, illness, stress, and other medications. Adjust your insulin dosage or meal plan as needed, in consultation with your doctor or diabetes educator.
• Consult your healthcare provider or pharmacist before taking any new medications, including over-the-counter drugs and herbal supplements, as they may interact with EGLUCENT MIX 50 and affect your blood sugar levels. Inform them about all the medications you are currently taking.
• Inspect the insulin visually before each use. Do not use EGLUCENT MIX 50 if it appears cloudy, thickened, or contains particles. Use only if it is uniformly cloudy. If you notice any abnormalities, discard the pen and use a new one.

• EGLUCENT MIX 50 PENFILL 3 ML should be administered 15 minutes before or immediately after meals. Consistent timing with meals is important to maintain stable blood sugar levels. Avoid significant changes in your diet without consulting your doctor.